Via the pathway analysis, we also found that CRKL is associated with a number of pathways, for instance, the MAPK signaling pathway, chronic myeloid leukemia and the regulation of the actin cytoskeleton pathways. This evidence concerns the gene CRKL and chronic myelogenous leukemia, BCR-ABL1 positive.